跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLUAIR INHALER fluticasone propionate 125 microgram/actuation inhalation pressurised aerosol can metered dose - TGA Drug Approval Details
Approvals
/
TGA
/
FLUAIR INHALER fluticasone propionate 125 microgram/actuation inhalation pressurised aerosol can metered dose
Approved
STANDARD
FLUAIR INHALER fluticasone propionate 125 microgram/actuation inhalation pressurised aerosol can metered dose
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
efd00664b5189ef1
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
efd00664b5189ef1
Product Name
FLUAIR INHALER fluticasone propionate 125 microgram/actuation inhalation pressurised aerosol can metered dose
Artg Id
270432
Artg Name
FLUAIR INHALER fluticasone propionate 125 microgram/actuation inhalation pressurised aerosol can metered dose
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2017-02-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
efd00664b5189ef1
Type
Standard
Back to TGA Approvals
